By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Myriad Genetics said Tuesday after the close of market that revenues for its fiscal fourth quarter rose 9 percent, with its women's health revenues bouncing 16 percent year over year.

The company also said that revenues rose 11 percent for full-year 2010 from full-year 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.